Brii Biosciences Ltd - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for AN2 THERAPEUTICS, INC. (ANTX)

Filing Manager: Brii Biosciences Ltd
Reporting Manager: Brii Biosciences Limited
Security: AN2 THERAPEUTICS, INC. Common Stock, $0.00001 par value per share
Symbol: ANTX
Shares outstanding: 29.9M shares
Disclosed Ownership: 927K shares
Ownership: 3.1%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 04:30 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Brii Biosciences Limited	3.1%	927K	927K	0	/s/ Ankang Li	Ankang Li, Executive Director, Chief Strategy and Financial Officer